相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chikungunya Vaccine Candidate Is Highly Attenuated and Protects Nonhuman Primates Against Telemetrically Monitored Disease Following a Single Dose
Chad J. Roy et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2014)
Clinical applications of attenuated MVA poxvirus strain
Carmen Elena Gomez et al.
EXPERT REVIEW OF VACCINES (2013)
A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice
Teck-Hui Teo et al.
JOURNAL OF IMMUNOLOGY (2013)
An Essential Role of Antibodies in the Control of Chikungunya Virus Infection
Fok-Moon Lum et al.
JOURNAL OF IMMUNOLOGY (2013)
High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome
Carmen E. Gomez et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
Fei Song et al.
JOURNAL OF VIROLOGY (2013)
Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response
David W. Hawman et al.
JOURNAL OF VIROLOGY (2013)
Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island
Jean-Jacques Hoarau et al.
PLOS ONE (2013)
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
Asisa Volz et al.
VACCINE (2013)
Recombinant MVA vaccines: dispelling the myths
Matthew G. Cottingham et al.
VACCINE (2013)
Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein El or E2 subunits
Stefan W. Metz et al.
VACCINE (2013)
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
Haiyan Chu et al.
VACCINE (2013)
Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
Joseph N. Brewoo et al.
VACCINE (2013)
Chikungunya and dengue autochthonous cases in Europe, 2007-2012
Danilo Tomasello et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
Chikungunya Virus Infection Results in Higher and Persistent Viral Replication in Aged Rhesus Macaques Due to Defects in Anti-Viral Immunity
Ilhem Messaoudi et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
Yiu-Wing Kam et al.
EMBO MOLECULAR MEDICINE (2012)
Chikungunya virus and prospects for a vaccine
Scott C. Weaver et al.
EXPERT REVIEW OF VACCINES (2012)
Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor
Susana Orozco et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Longitudinal Analysis of the Human Antibody Response to Chikungunya Virus Infection: Implications for Serodiagnosis and Vaccine Development
Yiu-Wing Kam et al.
JOURNAL OF VIROLOGY (2012)
The Alphavirus E3 Glycoprotein Functions in a Clade-Specific Manner
Anthony J. Snyder et al.
JOURNAL OF VIROLOGY (2012)
Deletion of Specific Immune-Modulatory Genes from Modified Vaccinia Virus Ankara-Based HIV Vaccines Engenders Improved Immunogenicity in Rhesus Macaques
David A. Garber et al.
JOURNAL OF VIROLOGY (2012)
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus
Manish Kumar et al.
VACCINE (2012)
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
Charalambos D. Partidos et al.
VACCINE (2012)
Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate
Christina L. Gardner et al.
VIROLOGY (2012)
Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice
Mohsin Khan et al.
VIRUS RESEARCH (2012)
MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
Carmen E. Gomez et al.
CURRENT GENE THERAPY (2011)
Genomic evolution and phenotypic distinctions of Chikungunya viruses causing the Indian Ocean outbreak
Ann M. Powers
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Chimeric Chikungunya Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but Efficiently Induce a Protective Immune Response
Eryu Wang et al.
JOURNAL OF VIROLOGY (2011)
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
Danher Wang et al.
VACCINE (2011)
Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling
Charalambos D. Partidos et al.
VACCINE (2011)
Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells
Stefan W. Metz et al.
VIROLOGY JOURNAL (2011)
Sequential Adaptive Mutations Enhance Efficient Vector Switching by Chikungunya Virus and Its Epidemic Emergence
Konstantin A. Tsetsarkin et al.
PLOS PATHOGENS (2011)
Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
Kenneth Plante et al.
PLOS PATHOGENS (2011)
An outbreak of chikungunya in southern Thailand from 2008 to 2009 caused by African strains with A226V mutation
Pornpimol Rianthavorn et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Chikungunya Virus Arthritis in Adult Wild-Type Mice
Joy Gardner et al.
JOURNAL OF VIROLOGY (2010)
T Cells Facilitate Recovery from Venezuelan Equine Encephalitis Virus-Induced Encephalomyelitis in the Absence of Antibody
Christopher B. Brooke et al.
JOURNAL OF VIROLOGY (2010)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
Joseph N. Brewoo et al.
VACCINE (2010)
Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes
Konstantin A. Tsetsarkin et al.
PLOS ONE (2009)
CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus
Nadezhda E. Yun et al.
VACCINE (2009)
A mouse model for chikungunya:: Young age and inefficient type-I interferon signaling are risk factors for severe disease
Therese Couderc et al.
PLOS PATHOGENS (2008)
A single mutation in chikungunya virus affects vector specificity and epidemic potential
Konstantin A. Tsetsarkin et al.
PLOS PATHOGENS (2007)
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection
Slobodan Paessler et al.
VIROLOGY (2007)
Outbreak of Chikungunya on Reunion Island: Early clinical and laboratory features in 157 adult patients
Gianandrea Borgherini et al.
CLINICAL INFECTIOUS DISEASES (2007)
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus
Ann M. Powers et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
E. Garcia-Hernandez et al.
CANCER GENE THERAPY (2006)
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis
Sarah C. Gilbert et al.
VACCINE (2006)
Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice
T Hanke et al.
VACCINE (2005)
Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels
MT Rock et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
PL Earl et al.
NATURE (2004)
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
VS Moorthy et al.
PLOS MEDICINE (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Clinical responses to undiluted and diluted smallpox vaccine
SE Frey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218
R Edelman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2000)
分享论文
